CNS
Areas of Expertise
Primary Areas of Focus
- Alzheimer’s Disease (AD) and related dementias, including:
- Prodromal/preclinical AD
- Mild Cognitive Impairment
- Mild to severe Alzheimer’s Disease (AD)
- Parkinson’s Disease & Dementia
- Vascular Dementia
Additional CNS Indications
- Frontotemporal Dementia
- Lewy-body Disease (LBD)
- Progressive Supranuclear Palsy (PSP), Multi-system Atrophy (MSA), Corticobasal Degeneration (CBD)
- Brain Health & Dementia prevention
- Headache
- Depression/Anxiety
- ADHD
Experience the PCR difference
Longstanding track record in CNS
With over 50 years of combined clinical and research experience, our principal investigators at PCR have developed a deep understanding of the complexities associated with CNS diseases. We are committed to contributing to the growing body of knowledge about Alzheimer’s disease and related disorders to determine best practices for optimal patient care.
Trials exceeding the highest standards
At PCR, we focus on meeting the highest scientific standards, while also enhancing patient experience and optimizing outcomes. This approach has made PCR a preferred partner for leading pharmaceutical companies in the Alzheimer’s and CNS space.
Widespread patient exposure
Our member clinics span across the US, giving us a diverse range of trial participants both geographically and demographically.
Quick Facts
- 14 sites nationwide with geographic reach in Texas, New Jersey, and South Carolina
- Team of leading principal investigators with over 50 years of combined therapeutic area expertise across Neurology, Neuropsychology, Geriatrics, and Internal Medicine.
- Experienced, highly qualified, and bilingual cognitive raters
- State-of-the-art facilities with dedicated testing rooms, infusion rooms, and highly trained/specialized staff
- Access to PET and advanced MRI
- Expedited timelines for budget/contract negotiation
- Expedited time to first patient screened and first patient randomized
English 
Spanish